132 related articles for article (PubMed ID: 4585343)
21. [Immunologic aspects of murine allogeneic tumor growth (author's transl)].
Braun M; Saal F; Pasqualini CD
Sangre (Barc); 1974; 19(2):153-7. PubMed ID: 4409784
[No Abstract] [Full Text] [Related]
22. Immunopotentiation with BCG. IV. Factors affecting the magnitude of an antitumor response.
Hawrylko E; Mackaness GB
J Natl Cancer Inst; 1973 Nov; 51(5):1683-8. PubMed ID: 4587143
[No Abstract] [Full Text] [Related]
23. Immunotherapy with tumor cells and BCG in the guinea pig, studied by immunological in vivo and in vitro experiments.
Rella W; Chaput B
Oncology; 1978; 35(3):136-42. PubMed ID: 209379
[TBL] [Abstract][Full Text] [Related]
24. [Phagocytic function of the macrophages in leukemic animals].
Fan FF
Eksp Med Morfol; 1976; 15(2):83-8. PubMed ID: 1278085
[TBL] [Abstract][Full Text] [Related]
25. T-cell-independent activation of macrophages by viable BCG in tumor-bearing mice.
Matsuo K; Takeya K; Nomoto K; Shimotori S; Terasaka R
Cell Immunol; 1981 Jan; 57(2):293-306. PubMed ID: 6783319
[No Abstract] [Full Text] [Related]
26. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
Mathé G; Weiner R; Pouillart P; Schwarzenberg L; Jasmin C; Schneider M; Hayat M; Amiel JL; de Vassal F; Rosenfeld C
Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314
[No Abstract] [Full Text] [Related]
27. Effect of cell-wall skeleton of Mycobacterium bovis BCG on cell-mediated cytotoxicity in tumor-bearing mice.
Taniyama T; Azuma I; Aladin AA; Yamamura Y
Gan; 1975 Dec; 66(6):705-9. PubMed ID: 817955
[TBL] [Abstract][Full Text] [Related]
28. Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG.
Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
J Natl Cancer Inst; 1973 Dec; 51(6):1897-908. PubMed ID: 4358147
[No Abstract] [Full Text] [Related]
29. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
Gordon WC; Prager MD
Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
[TBL] [Abstract][Full Text] [Related]
30. Suppression of murine tumor growth by immune reaction to the Bacillus Calmette-Guérin strain of Mycobacterium bovis.
Bartlett GL; Zbar B; Rapp HJ
J Natl Cancer Inst; 1972 Jan; 48(1):245-57. PubMed ID: 4568964
[No Abstract] [Full Text] [Related]
31. Relationship between intradermal tumor suppression and tumor immunity.
Bartlett GL; Kreider JW; Purnell DM
J Natl Cancer Inst; 1976 Dec; 57(6):1297-303. PubMed ID: 794505
[TBL] [Abstract][Full Text] [Related]
32. Immune inhibition of allogeneic lymphoma cells in the peritoneal cavity of mice.
Fioretti MC; Libarati M; Bonmassar E; Cudkowicz G
Cancer Res; 1975 Jan; 35(1):30-6. PubMed ID: 1089042
[TBL] [Abstract][Full Text] [Related]
33. Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents.
Germain RN; Williams RM; Benacerraf B
J Natl Cancer Inst; 1975 Mar; 54(3):709-20. PubMed ID: 1091741
[TBL] [Abstract][Full Text] [Related]
34. Histopathology of Mycobacterium bovis (BCG)-mediated tumor regression.
Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
Natl Cancer Inst Monogr; 1972 Dec; 35():345-58. PubMed ID: 4349152
[No Abstract] [Full Text] [Related]
35. Isolation of a subpopulation of adherent peritoneal cells with anti-tumour activity.
Nathan CF; Hill VM; Terry WD
Nature; 1976 Mar; 260(5547):146-8. PubMed ID: 768773
[No Abstract] [Full Text] [Related]
36. Interaction of macrophages with tumor cells.
Stewart CC; Adles C; Hibbs JB
Adv Exp Med Biol; 1976; 73 Pt B():423-33. PubMed ID: 793342
[No Abstract] [Full Text] [Related]
37. Effect of intratumor injection of live BCG on 3-methylcholanthrene-induced tumors of primary and early transplant generations in mice.
Tanaka T
Gan; 1974 Apr; 65(2):145-51. PubMed ID: 4600803
[No Abstract] [Full Text] [Related]
38. Antigen driven selection for Fc receptors of enhancing antibody on macrophages during an alloimmune response.
Whitten HD; Cruse JM; Lewis GK; Watson ES
J Reticuloendothel Soc; 1974 Feb; 15(2):118-25. PubMed ID: 4815211
[No Abstract] [Full Text] [Related]
39. Active immunoprophylaxis and immunotherapy in two mouse lymphoma models.
Ghose T; Guclu A; Tai J; Norvell ST; MacDonald AS
J Natl Cancer Inst; 1976 Aug; 57(2):303-15. PubMed ID: 794497
[TBL] [Abstract][Full Text] [Related]
40. Augmentation of the adoptive transfer of specific tumor immunity by non-specifically immunized macrophages.
Ariyan S; Gershon RK
J Natl Cancer Inst; 1973 Oct; 51(4):1145-8. PubMed ID: 4583372
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
